[Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001578:Benzopyrans / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology*; D004983:Ethanolamines / Q000494:pharmacology* / Q000627:therapeutic use*; D015444:Exercise; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000068577:Nebivolol; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001578:Benzopyrans; D004983:Ethanolamines; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D000068577:Nebivolol; D009569:Nitric Oxide
Betablocker verbessert die Endothelfunktion. Gasförmiger Gefässschutz.